Anne B. Tjensvoll

Stavanger, 4068, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.

Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.

Journal: Journal of neurology

Published: March 23, 2024

Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.

Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.

Journal: Journal of neurology

Published: September 09, 2021

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.

Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.

Journal: Journal of neurology

Published: July 09, 2020

Fatigue in primary Sjögren's syndrome: A proteomic pilot study of cerebrospinal fluid.

Fatigue in primary Sjögren's syndrome: A proteomic pilot study of cerebrospinal fluid.

Journal: SAGE open medicine

Published: January 17, 2019

Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren's syndrome.

Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren's syndrome.

Journal: Journal of neuroinflammation

Published: October 06, 2018

The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.

The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.

Journal: Lupus

Published: October 05, 2018

Severe headache in primary Sjögren's syndrome treated with intrathecal rituximab.

Severe headache in primary Sjögren's syndrome treated with intrathecal rituximab.

Journal: Clinical case reports

Published: October 01, 2018

Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies.

Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies.

Journal: European journal of neurology

Published: July 08, 2015

Reply: To PMID 25156222.

Reply: To PMID 25156222.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 18, 2015

Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.

Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 17, 2014

A rapid method for preparation of the cerebrospinal fluid proteome.

A rapid method for preparation of the cerebrospinal fluid proteome.

Journal: Proteomics

Published: March 17, 2014

Loss of cerebral white matter in primary Sjögren's syndrome: a controlled volumetric magnetic resonance imaging study.

Loss of cerebral white matter in primary Sjögren's syndrome: a controlled volumetric magnetic resonance imaging study.

Journal: European journal of neurology

Published: February 17, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026